Echo Therapeutics (NASDAQ: ECTE) and Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitabiliy, valuation, earnings, risk and institutional ownership.

Insider and Institutional Ownership

17.8% of Tonix Pharmaceuticals Holding Corp. shares are owned by institutional investors. 4.0% of Tonix Pharmaceuticals Holding Corp. shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Volatility and Risk

Echo Therapeutics has a beta of 1.14, suggesting that its stock price is 14% more volatile than the S&P 500. Comparatively, Tonix Pharmaceuticals Holding Corp. has a beta of 2.84, suggesting that its stock price is 184% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for Echo Therapeutics and Tonix Pharmaceuticals Holding Corp., as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Echo Therapeutics 0 0 0 0 N/A
Tonix Pharmaceuticals Holding Corp. 0 3 1 0 2.25

Tonix Pharmaceuticals Holding Corp. has a consensus target price of $7.50, suggesting a potential upside of 72.81%. Given Tonix Pharmaceuticals Holding Corp.’s higher probable upside, analysts plainly believe Tonix Pharmaceuticals Holding Corp. is more favorable than Echo Therapeutics.

Profitability

This table compares Echo Therapeutics and Tonix Pharmaceuticals Holding Corp.’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Echo Therapeutics N/A N/A 216.11%
Tonix Pharmaceuticals Holding Corp. N/A -107.33% -97.16%

Earnings & Valuation

This table compares Echo Therapeutics and Tonix Pharmaceuticals Holding Corp.’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Echo Therapeutics N/A N/A N/A ($1.48) -0.03
Tonix Pharmaceuticals Holding Corp. N/A N/A -$29.87 million ($11.25) -0.39

Tonix Pharmaceuticals Holding Corp. is trading at a lower price-to-earnings ratio than Echo Therapeutics, indicating that it is currently the more affordable of the two stocks.

Summary

Tonix Pharmaceuticals Holding Corp. beats Echo Therapeutics on 5 of the 8 factors compared between the two stocks.

About Echo Therapeutics

Echo Therapeutics, Inc. is a medical device company. The Company is engaged in developing a non-invasive, wireless continuous glucose monitoring (CGM) system with use in the wearable-health consumer market, diabetes outpatient market and in the hospital setting. The Company operates through the development of transdermal skin permeation and diagnostic medical devices segment. The Company has also developed its needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, enhanced delivery of topical pharmaceuticals and other applications. The CGM System includes a skin preparation device, transdermal glucose sensor, battery and wireless transmitter. The Company has conducted several human feasibility clinical studies with its CGM System in healthy subjects, diabetics and critically ill patients, as well as a clinical study at several hospitals in the United States.

Receive News & Ratings for Echo Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Echo Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.